MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F

Molecular and Cellular Biology

Volumn 32, Issue 3, 2012, Pages 633-651

  Jurmeister, Sarah ^a,b   Baumann, Marek ^a,c   Balwierz, Aleksandra ^a   Keklikoglou, Ioanna ^a   Ward, Aoife ^a   Uhlmann, Stefan ^a   Zhang, Jitao David ^a,d   Wiemann, Stefan ^a   Sahin, Özgür ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN REGULATORY PROTEIN; FORMIN HOMOLOGY 2 DOMAIN CONTAINING 1 PROTEIN; MICRORNA; MICRORNA 200C; MYCOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN; MYOSIN LIGHT CHAIN 2; PROTEIN PHOSPHATASE, MAGNESIUM MANGANESE DEPENDENT, 1F PROTEIN; REGULATOR PROTEIN; SERUM RESPONSE FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ELONGATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUSCLE CONTRACTILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RNA INTERFERENCE; STRESS FIBER;

BREAST NEOPLASMS; CARDIAC MYOSINS; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MYOSIN LIGHT CHAINS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PHOSPHOPROTEIN PHOSPHATASES; SERUM RESPONSE FACTOR; STRESS FIBERS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863012099     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06212-11     Document Type: Article

References (49)

1. Ahmad A, et al. 2011. Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res. 71:3400 -3409.
2. Blick T, et al. 2008. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25:629-642.
3. Burk U, et al. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9:582-589.
4. Copeland JW, Treisman R. 2002. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization. Mol. Biol. Cell 13:4088-4099.
5. Das S, Becker BN, Hoffmann FM, Mertz JE. 2009. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol. 10:94.
6. Edlund S, Landstrom M, Heldin CH, Aspenstrom P. 2002. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 13: 902-914.
7. Elson-Schwab I, Lorentzen A, Marshall CJ. 2010. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 5:e13176.
8. Enerly E, et al. 2011. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6:e16915.
9. Gasteier JE, et al. 2003. Activation of the Rac-binding partner FHOD1 induces actin stress fibers via a ROCK-dependent mechanism. J. Biol. Chem. 278:38902-38912.
10. Gasteier JE, et al. 2005. FHOD1 coordinates actin filament and microtubule alignment to mediate cell elongation. Exp. Cell Res. 306:192-202. 11.
11. Gibbons DL, et al. 2009. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 23:2140 -2151.
12. Gilles L, et al. 2009. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. Blood 114:4221- 4232.
13. Gregory PA, et al. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10:593- 601.
14. Gregory PA, et al. 2011. An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelialmesenchymal transition. Mol. Biol. Cell. 22:1686-1698.
15. Howe EN, Cochrane DR, Richer JK. 2011. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13:R45.
16. Hu X, et al. 2009. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol. Oncol. 114:457- 464.
17. Hurteau GJ, Carlson JA, Roos E, Brock GJ. 2009. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 8:2064 -2069.
18. Iliopoulos D, et al. 2010. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol. Cell 39:761-772.
19. Koh CG, Tan EJ, Manser E, Lim L. 2002. The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family. Curr. Biol. 12:317-321.
20. Kong D, et al. 2009. miR-200 regulates PDGF-D-mediated epithelialmesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712-1721.
21. Korpal M, et al. 2011. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 17:1101-1108.
22. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283:14910 -14914.
23. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
24. Lombaerts M, et al. 2006. E-cadherin transcriptional downregulation by promotermethylationbutnotmutationisrelatedtoepithelial-to-mesenchymaltransition in breast cancer cell lines. Br. J. Cancer 94:661-671.
25. Madrid R, et al. 2005. Oligomerization of the diaphanous-related formin FHOD1 requires a coiled-coil motif critical for its cytoskeletal and transcriptional activities. FEBS Lett. 579:441- 448.
26. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. 2009. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 11:257-268.
27. Miano JM, Long X, Fujiwara K. 2007. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292:C70-C81.
28. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113:329-342.
29. Neve RM, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527.
30. Olson P, et al. 2009. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 23:2152-2165.
31. Park SM, Gaur AB, Lengyel E, Peter ME. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22:894-907.
32. Row RH, et al. 2011. Completion of the epithelial to mesenchymal transition in zebrafish mesoderm requires Spadetail. Dev. Biol. 354:102-110.
33. Sahin O, et al. 2009. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance.BMC Syst. Biol. 3:1.
34. Schickel R, Park SM, Murmann AE, Peter ME. 2010. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol. Cell 38: 908-915.
35. Shen X, et al. 2001. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J. Biol. Chem. 276:15362-15368.
36. Solly K, Wang X, Xu X, Strulovici B, Zheng W. 2004. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol. 2:363-372.
37. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. 1994. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat. 31:325-335.
38. Sossey-Alaoui K, Bialkowska K, Plow EF. 2009. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J. Biol. Chem. 284:33019-33029.
39. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. 1999. Signalregulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98:159-169.
40. Susila A, et al. 2010. The POPX2 phosphatase regulates cancer cell motility and invasiveness. Cell Cycle 9:179-187.
41. Takeya R, Sumimoto H. 2003. Fhos, a mammalian formin, directly binds to F-actin via a region N-terminal to the FH1 domain and forms a homotypic complex via the FH2 domain to promote actin fiber formation. J. Cell Sci. 116:4567-4575.
42. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelialmesenchymal transitions in development and disease. Cell 139:871- 890.
43. Uhlmann S, et al. 2010. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29:4297-4306.
44. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Nonmuscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 10:778-790.
45. Westendorf JJ. 2001. The formin/diaphanous-related protein, FHOS, interacts with Rac1 and activates transcription from the serum response element. J. Biol. Chem. 276:46453- 46459.
46. Westendorf JJ, Koka S. 2004. Identification of FHOD1-binding proteins and mechanisms of FHOD1-regulated actin dynamics. J. Cell Biochem. 92:29-41.
47. Wiklund ED, et al. 2011. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer 128: 1327-1334.
48. Xie Y, et al. 2008. Functional interactions between phosphatase POPX2 and mDia modulate RhoA pathways. J. Cell Sci. 121:514 -521.
49. Yu J, et al. 2010. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol. Cancer. 9:169.